Jerusalem: On Dec 29, Israel’s Oramed Pharmaceuticals announced that its Oravax Medical unit had signed a deal with Vietnam’s Tan Thanh Holdings for the pre-order of 10 million doses of its oral COVID-19. The said COVID-19 vaccine is in clinical trials. Nadav Kidron, chief executive of Oramed, said its oral COVID vaccine was undergoing Phase I clinical trials, and results should be available in early 2022.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Israeli army issues northern Gaza eviction order ahead of strike

The Israeli military on Tuesday issued an eviction order for residents in…

11 dead, 63 wounded in Israeli strike on central Beirut

Lebanon’s health ministry said an Israeli strike that hit a central Beirut…

Israeli shelling kills two UNRWA workers in Gaza

Two employees of the UN’s relief agency for Palestinian refugees (UNRWA) were…

Covid-19 rises again in Lahore

Lahore: Covid-19 has again surged to a dangerous level. The rate of…